Mefenamic Acid Chemidex Pharma

Mefenamic Acid, the active ingredient in Mefenamic Acid Chemidex Pharma, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve mild to moderate pain, dysmenorrhea and various inflammatory conditions in adults. GNH USA supplies Mefenamic Acid Chemidex Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mefenamic Acid acts as an NSAID to reduce pain and inflammation in several common conditions.

Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal aches. Dysmenorrhea: alleviates menstrual cramps and associated discomfort. Inflammatory conditions: reduces swelling and pain in conditions such as osteoarthritis and rheumatoid arthritis.

Mefenamic Acid may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea or upset stomach - Dyspepsia or heartburn - Headache - Dizziness - Mild rash or itching - Diarrhoea

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Acute renal impairment - Hepatic dysfunction or jaundice - Severe skin reactions such as Stevens‑Johnson syndrome - Anaphylactic or anaphylactoid reactions - Blood dyscrasias including agranulocytosis

Before prescribing Mefenamic Acid, clinicians should consider several safety factors. - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Monitor renal function: use caution in patients with impaired kidney function. - Use lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Pregnancy and breastfeeding: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Mefenamic Acid can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin: increased risk of bleeding. - Lithium: may raise lithium serum levels. - Methotrexate: enhanced toxicity. - Other NSAIDs or aspirin: heightened gastrointestinal and renal adverse effects. - ACE inhibitors: potential reduction in renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal impairment. - Corticosteroids: increased risk of GI ulceration. - SSRIs or SNRIs: additive bleeding risk. - Antihypertensives: possible reduction in blood pressure control. - Oral hypoglycemics: may affect glucose control.